Further experiments are needed to elucidate the molecular mechanisms of antigen processing and presentation affected by SDC1 in the carcinogenesis of glioma, which may lead to a novel prognostic indicator and more effective treatment strategies. The gene discussed is SDC1; the disease is glioma.